Tag: WS Audiology

All

Latest

Carsten Buhl Named President of Newly-formed WSA Americas

WS Audiology announced the formation of WSA Americas and appointed medical device and WSA veteran Carsten Buhl to serve as president of the new regional business unit, effective immediately, reporting to Eric Bernard, WS Audiology Group CEO.

WSA Releases 2020/21 Annual Report

WSA grew revenue organically by 22% to pass the EUR 2 billion mark (USD $2.3 billion) and simultaneously delivered a historically strong normalized EBITDA of EUR 464 million (USD $524 million) – an increase of 40% compared to the year before, according to the announcement.

Read More

WS Audiology Group CFO Søren Westh Lonning Resigns

WS Audiology announced that its Group CFO Søren Westh Lonning will step down on November 8, 2021, to fully focus on recovering from back pain issues. Michael Tyroller will assume the position as interim Group CFO from the same date after previously having acted as interim Group CFO of WS Audiology from June 1 until October 31, 2020.

Read More

Neuromod Appoints Eric Timm as US CEO

Neuromod Devices Ltd, the medical device company which specializes in neuromodulation technologies, has announced the appointment of Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc, effective from October 1, 2021.

Read More

Neuromod Opens USA HQ

Neuromod Devices Ltd, the Irish medical device company specializing in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc, headquartered in Oak Brook, Ill. Three executives with significant experience in the hearing health industry have been appointed to the Neuromod USA leadership team as the organization prepares to enter the US market with its medical device for tinnitus treatment, pending approval from the Food and Drug Administration (FDA).

Read More

WS Audiology Announces ‘Strong Revenue’ in HI 2020/21

WS Audiology announced that the company generated what it reports as strong revenue and earnings growth in the first half (H1) of its fiscal year (October 2020 through March 2021) in the face of the COVID-19 pandemic. According to its announcement, WS Audiology has continued to bring innovative products to market and has “upgraded the full-year revenue and profitability outlook.”

Read More
Loading